The American Heart Association (AHA) is promoting its new Science and Technology Accelerator Program in a video that highlights CytoVas, LLC, its first investment recipient company. The company was founded by Department of Pathology faculty members Jonni S. Moore, PhD, and Wade Rogers, PhD, and Emile R. Mohler III, MD, Department of Medicine, Cardiovascular Division. Cytovas is developing a vascular health profile to measure major indicators of blood vessel health by measuring blood-vessel stem cells and the amount of microparticles through a new analysis method termed cytometric fingerprinting. This method automates the task of analyzing large, complex datasets from flow cytometry of the blood vessel cells.